Tactile Medical sets November 2 results date for Tactile Medical stock

Published on 10/20/2026 at 13:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Tactile Medical stock costs EUR 20.28 on October 20, 2026 at Lang & Schwarz. Second-quarter revenue was USD 85.70 million.

Upcoming results and analyst targets

Tactile Medical scheduled fiscal third-quarter results for November 2, 2026.
Second-quarter revenue reached USD 85.70 million and diluted earnings per share were USD 0.34.
Tactile Medical stock was trading at EUR 20.28 at 1:35 p.m. CEST at Lang & Schwarz on October 20, 2026.
BTIG cut its target from USD 39.00 to USD 35.00 on October 12, 2026.

TCMD, US87357P1003, Illustration mit AI erstellt.

Tactile Medical (US87357P1003) was trading at EUR 20.28 at Lang & Schwarz on October 20, 2026 at 1:35 p.m. CEST. StockTitan reported that the company will release its fiscal third-quarter results after the market closes on November 2, 2026.

Results date sets the next checkpoint

The November 2 release is the clearest near-term event for Tactile Medical stock. Management also scheduled a conference call for 5:00 p.m. Eastern Time, giving investors a second checkpoint on the same day, according to StockTitan.

The latest reported quarter provides the operating benchmark. In the second quarter of fiscal 2026, revenue was USD 85.70 million and diluted earnings per share were USD 0.34, compared with USD 85.52 million and USD 0.14 consensus revenue and earnings expectations, respectively, according to MarketBeat. The revenue comparison was modest, while the earnings comparison was materially stronger.

What does the target cut change?

BTIG lowered its price target from USD 39.00 to USD 35.00 on October 12, 2026, while retaining a Buy rating, as Markets Insider reported. The change leaves the upcoming quarter responsible for testing whether recent growth can support the lower target.

Three dated signals for TCMD

On August 10, 2026, Tactile Medical reported second-quarter revenue of USD 85.70 million and diluted earnings per share of USD 0.34, according to MarketBeat. On October 12, 2026, BTIG cut its target from USD 39.00 to USD 35.00, according to Markets Insider. On October 19, 2026, the company announced that fiscal third-quarter results would arrive on November 2, 2026, as reported by StockTitan.

Dates investors can mark

The next scheduled date is November 2, 2026, for fiscal third-quarter results after the market close and the 5:00 p.m. Eastern Time conference call.

Stock stays below its yearly high

Tactile Systems Technology is a medical-device company focused on at-home therapies for chronic swelling and respiratory conditions. Its primary listing is Nasdaq under ticker TCMD. MarketBeat reported a 52-week range of USD 14.00 to USD 37.77 on October 12, 2026, placing the stock's operating story against a broad valuation range.

The stock was trading at EUR 20.28 at Lang & Schwarz on October 20, 2026 at 1:35 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Tactile Medical stock.